← SynDRA
CEFMETAZOLE
SynDRA canonical compound SYN0023459 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Mechanism of action | bacterial cell wall synthesis inhibitor |
| Indication | skin infections | urinary tract infections |
| Disease area | infectious disease |
All known targets
- Bact mrcA
- IDE
- dacA
- dacB
- dacC
- ftsI
- mrcA
- mrcB
- mrdA
- pbpA
Mechanisms of action (all sources)
- bacterial cell wall synthesis inhibitor
- Bact mrcA BINDER
- mrcA INHIBITOR
- mrcB INHIBITOR
- dacC INHIBITOR
- mrdA INHIBITOR
- ftsI INHIBITOR
- dacA INHIBITOR
- dacB INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCC2
- MAPK14
- OPRK1
- OPRD1
- NR3C1
- NPY2R
- NPY1R
- MPHOSPH8
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK1
- PDE3A
- MAOA
- LCK
- KCNH2
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- OPRM1
- PDE4A
- HDAC6
- SIGMAR1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SMN1
- SMAD3
- SLCO1B3
- SLCO1B1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP1A2
- CTDS1
- DNMT1
- FGF22
- GLSK
- GPR32
- GPX1
- NTM1A
- NTMT1
- UHRF1
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- J01D · OTHER BETA-LACTAM ANTIBACTERIALS
Cross-references
Synonyms
- ZEFAZONE
- ZEFAZONE IN PLASTIC CONTAINER
- cefmetazole sodium
- cefmetazole sodium salt
- Cefmetazol
- U-72791
- CMZ
- Cefmetazolo
- Cefmetazolum
- Cefmetazole Monosodium Salt
- CS-1170
- SKF 83088
- U 72791
- Cefmetazole [USAN:INN]
- Cefmetazolo [INN-Spanish]
- Cefmetazolum [INN-Latin]
- U-72791A
- Cefmetazole (USP/INN)
- 3J962UJT8H
- CHEBI:3489
- RefChem:574974
- DTXCID502756
- J01DA40
- CS1170
- MFCD00865068
- CS 1170
- C15H17N7O5S3
- EINECS 260-384-2
- BRN 0634647
- UNII-3J962UJT8H
- Cefmetazole [USAN:USP:INN]
- CefmetaZole, 95%
- CEFMETAZOLE [MI]
- Prestwick0_000700
- Prestwick1_000700
- Prestwick2_000700
- Prestwick3_000700
- CEFMETAZOLE [INN]
Look up CEFMETAZOLE in the interactive SynDRA portal →